SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyResearch in context

Summary: Background: The optimal timing for SARS-CoV-2 vaccines within the first year after allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We conducted a prospective, multicentre, observational study of allogeneic HCT recipients who initiated SARS-CoV-2 vaccinations w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V. Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir A. Toor, Stephanie Waldvogel, Lee M. Greenberger, Jeffery J. Auletta, Mary M. Horowitz, Marcie L. Riches, Miguel-Angel Perales
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-05-01
coleção:	EClinicalMedicine
Assuntos:	SARS-CoV-2 Covid-19 Vaccine Transplant Hematopoietic cell transplant
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2589537023001608
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!